The comparative study for dd-eob-dtpa enhanced magnetic resonance imaging and enhanced CT in hepatic metastasis of pancreatic cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900022842

Enrollment

Unknown

Registered

2019-04-28

Start date

2019-06-01

Completion date

Unknown

Last updated

2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic metastasis in pancreatic

Interventions

Gold Standard:dd-eob-dtpa enhanced magnetic resonance imaging (MRI)

Index test:enhanced CT

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Cases clinically diagnosed as pancreatic cancer; 2. Older than 18 years; 3. normal or mild damage to heart, lung, liver, kidney and other important organs.

Exclusion criteria

Exclusion criteria: 1. No follow-up data were available 2. Only one of the enhanced CT or PMR was performed; 3. Pregnant women 4. With intrahepatic or extrahepatic metastasis.

Design outcomes

Primary

Measure	Time frame
Liver metastases;	—

Countries

China

Contacts

Public ContactLi Jiangfa

Affiliated Hospital of Guilin Medical University

247546160@qq.com+86 0773-2824373

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026